OR WAIT null SECS
February 01, 2019
Sphere Fluidics has closed its latest investment round in which it raised US$2 million (approximately £1.5 million).
The acquisition will boost Hitachi Chemical’s presence in the European regenerative medicines market.
Janssen and MeiraGTx will collaborate on the development and commercialization of gene therapies for treating inherited retinal diseases.
January 25, 2019
Full commercial launch of the drug is underway in the United States, with Europe to follow.
January 17, 2019
A strategic collaboration has been formed between 4D pharma and The University of Texas MD Anderson Cancer Center.
Solentim and ATUM have announced a technology collaboration agreement that will focus on the creation of an efficient cell line development solution for biotherapeutic drug developers.
Lonza and Takeda have furthered their multiproduct partnership through collaborative efforts on a new cancer treatment-Alunbrig (brigatinib).
The Centre for Process Innovation (CPI) has led an Innovate UK project focused on the establishment of a generic framework and core capability to improve industrial productivity using computer models.
Almac Sciences has announced the expansion of its technology capabilities within its API services and chemical development portfolio through implementation of continuous flow expertise.
The companies will offer an IT platform that enhances the visibility and performance of the overall personalized medicine treatment process.